Application of nanobiotechnology in cancer therapeutics

Pharmaceutical Perspectives of Cancer Therapeutics

Volumn , Issue , 2009, Pages 245-268

  Jain, K K ^a  

^a JAIN PHARMABIOTECH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650506351     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-0131-6_8     Document Type: Chapter

References (62)

1. Jain KK. A Handbook of Nanomedicine. Humana/Springer, Totowa, NJ, 2008.
2. Jain KK. Recent Advances in Nanooncology. Technol Cancer Res Treat 2008;7:1-13.
3. Jain KK. Applications of Nanobiotechnology in Clinical Diagnostics. Clin Chem 2007;53:2002-2009.
4. Jain KK. Role of nanobiotechnology in drug discovery. In: Guzman CA, Feuerstein G (eds) Pharmaceutical Biotechnology. Austin, TX, Landes Press, 2009.
5. Jain KK. Nanotechnology-based drug delivery for cancer. Technol Cancer Res Treat 2005;4:407-416.
6. Jain KK. Cancer Biomarkers: Current issues and future directions. Curr Opin Mol Ther 2007;9:563-571.
7. Zheng G, Patolsky F, Cui Y, et al. Multiplexed electrical detection of cancer markers with nanowire sensor arrays. Nat Biotechnol 2005;23:1294-1301.
8. Singer EM, Smith SS. Nucleoprotein Assemblies for Cellular Biomarker Detection. Nano Lett 2006;6:1184-1189.
9. Jain KK. Nanobiotechnology: Applications, Markets and Companies. Basel, Jain Pharma-Biotech, 2009.
10. Zharov VP, Galitovskaya EN, Johnson C, Kelly T. Synergistic enhancement of selective nanophotothermolysis with gold nanoclusters: Potential for cancer therapy. Lasers Surg Med 2005;37:219-226.
11. Li J, Wang X, Wang C, et al. The enhancement effect of gold nanoparticles in drug delivery and as biomarkers of drug-resistant cancer cells. ChemMedChem 2007;2:374-378.
12. Jain PK, Huang X, El-Sayed IH, El-Sayed MA. Noble metals on the nanoscale: Optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. Acc Chem Res 2008c May 1; doi:10.1021/ ar7002804.
13. Wu Q, Cao H, Luan Q, et al. Biomolecule-assisted synthesis of water-soluble silver nanoparticles and their biomedical applications. Inorg Chem 2008;47:5882-5888.
14. Bagalkot V, Zhang L, Levy-Nissenbaum E, et al. Quantum Dot-Aptamer Conjugates for Synchronous Cancer Imaging, Therapy, and Sensing of Drug Delivery Based on Bi-Fluorescence Resonance Energy Transfer. Nano Lett 2007;7:3065-3070.
15. Yu X, Munge B, Patel V, et al. Carbon nanotube amplification strategies for highly sensitive immunodetection of cancer biomarkers. J AmChemSoc 2006;128:11199-11205.
16. Bianco A, Kostarelos K, Prato M. Opportunities and challenges of carbon-based nanomaterials for cancer therapy. Expert Opin Drug Deliv 2008;5:331-342.
17. Hampel S, Kunze D, Haase D, et al. Carbon nanotubes filled with a chemotherapeutic agent: a nanocarrier mediates inhibition of tumor cell growth. Nanomedicine 2008;3:175-182.
18. Reddy GR, Bhojani MS, McConville P, et al. Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin Cancer Res 2006;12:6677-6686.
19. Simberg D, Duza T, Park JH, et al. Biomimetic amplification of nanoparticle homing to tumors. Proc Natl Acad Sci 2007;104:932-936.
20. Rabin O, Manuel Perez J, Grimm J. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater 2006;5:118-122.
21. Gao D, Xu H, Philbert MA, et al. Ultrafine Hydrogel Nanoparticles: Synthetic Approach and Therapeutic Application in Living Cells. Angew Chem Int Ed Engl 2007;46:2224-2227.
22. Choi J, Jun. Y, Yeon S, et al. Biocompatible Heterostructured Nanoparticles for Multimodal Biological Detection. JACS 2006;128:5982-15983.
23. Talanov VS, Regino CA, Kobayashi H, et al. Dendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imaging. Nano Lett 2006;6:1459-1463.
24. Koster DA, Palle K, Bot ES, et al. Antitumour drugs impede DNA uncoiling by topoisomerase I. Nature 2007;448:213-217.
25. Roovers RC, Laeremans T, Huang L, et al. Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies. Cancer Immunol Immunother 2007;56:303-317.
26. Gao X, Dave SR. Quantum dots for cancer molecular imaging. Adv Exp Med Biol 2007;620:57-73.
27. Koo OM, Rubinstein I, Onyuksel H. Camptothecin in sterically stabilized phospholipid nano-micelles: A novel solvent pH change solubilization method. J Nanosci Nanotechnol 2006;6:2996-3000.
28. Geng Y, Dalhaimer P, Cai S, et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotech 2007;2:249-255.
29. Sutton D, Nasongkla N, Blanco E, Gao J. Functionalized Micellar Systems for Cancer Targeted Drug Delivery. Pharmaceutical Res 2007;24:1029-1046.
30. Lu J, Liong M, Zink JI, Tamanoi F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 2007;3:1341-1346.
31. MacDiarmid JA, Mugridge NB, Weiss JC, et al. Bacterially Derived 400 nm Particles for Encapsulation and Cancer Cell Targeting of Chemotherapeutics. Cancer Cell 2007;11:431-445.
32. Wagner E. Programmed drug delivery: Nanosystems for tumor targeting. Expert Opin Biol Ther 2007;7:587-593.
33. Radosz M, Shen Y, Tang H. Nanoparticles for Cytoplasmic Drug Delivery to Cancer Cells. Patent #WO/2007/001356, Publication Date 4 January 2007.
34. Lee CC, Gillies ER, Fox ME. A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas. Proc Natl Acad Sci 2006;103:16649-16654.
35. McDevitt MR, Chattopadhyay D, Kappel BJ, et al. Tumor targeting with antibodyfunctionalized, radiolabeled carbon nanotubes. J Nucl Med 2007;48:1180-1189.
36. Ashcroft JM, Tsyboulski DA, Hartman KB, et al. Fullerene (C60) immunoconjugates: Interaction of water-soluble C60 derivatives with the murine anti-gp240 melanoma antibody. Chem Commun 2006;28:3004-3006.
37. Kano MR, Bae Y, Iwata C, et al. Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-{beta} signaling. Proc Natl Acad Sci 2007;104:3460-3465.
38. Qian X, Peng XH, Ansari DO, et al. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat Biotech 2008;26:83-90.
39. Jia N, Lian Q, Shen H, et al. Intracellular delivery of quantum dots tagged antisense oligodeoxynucleotides by functionalized multiwalled carbon nanotubes. Nano Lett 2007;7:2976-2980.
40. Liu Z, Chen K, Davis C, et al. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res 2008;68:6652-6660.
41. Murakami T, Sawada H, Tamura G, et al. Water-dispersed single-wall carbon nanohorns as drug carriers for local cancer chemotherapy. Nanomed 2008;3:453-463.
42. Ahmed F, Pakunlu RI, Srinivas G, et al. Shrinkage of a rapidly growing tumor by drugloaded polymersomes: pH-triggered release through copolymer degradation. Mol Pharm 2006;3:340-350.
43. Bertin PA, Gibbs JM, Shen CK, et al. Multifunctional polymeric nanoparticles from diverse bioactive agents. J Am Chem Soc 2006;128:4168-4169.
44. Peng W, Anderson DG, Bao Y, et al. Nanoparticulate delivery of suicide DNA to murine prostate and prostate tumors. Prostate 2007;67:855-862.
45. Jain KK. Use of nanoparticles for drug delivery in glioblastoma multiforme. Expert Rev Neurother 2007;7:363-372.
46. van Vlerken LE, Duan Z, Seiden MV, Amiji MM. Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer. Cancer Res 2007;67:4843-4850.
47. Cinteza LO, Ohulchanskyy TY, Sahoo Y, et al. Diacyllipid Micelle-Based Nanocarrier for Magnetically Guided Delivery of Drugs in Photodynamic Therapy. Mol Pharm 2006;3:415-423.
48. Ohulchanskyy TY, Roy I, Goswami LN, Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer. Nano Lett 2007;7:2835-2842.
49. Rapoport N, Gao Z, Kennedy A. Multifunctional Nanoparticles for Combining Ultrasonic Tumor Imaging and Targeted Chemotherapy. J Natl Cancer Inst 2007;99:1095-1106.
50. Johannsen M, Gneveckow U, Thiesen B, et al. Thermotherapy of prostate cancer using magnetic nanoparticles: Feasibility, imaging, and three-dimensional temperature distribution. Eur Urol 2007;52:1653-1661.
51. Lehmann J, Natarajan A, Denardo GL, et al. Short communication: nanoparticle thermotherapy and external beam radiation therapy for human prostate cancer cells. Cancer Biother Radiopharm 2008;23:265-271.
52. Huang X, El-Sayed IH, Qian W, El-Sayed MA. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 2006;128:2115-2120.
53. Everts M. Thermal scalpel to target cancer. Expert Rev Med Devices 2007;4:131-136.
54. Tomalia DA, Reyna LA, Svenson S. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem Soc Trans 2007;35:61-67.
55. Robe A, Pic E, Lassalle HP, et al. Quantum dots in axillary lymph node mapping: Biodistribution study in healthy mice. BMC Cancer 2008;8:111.
56. Wang P, Jia L, Sanders BG, Kline K. Liposomal or nanoparticle alpha-TEA reduced 66 cl-4 murine mammary cancer burden and metastasis. Drug Deliv 2007;14:497-505.
57. Gordon EM, Levy JP, Reed RA, et al. Targeting metastatic cancer from the inside: A new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ. Int J Oncol 2008;33:665-675.
58. Jain KK. Role of nanobiotechnology in developing personalized medicine for cancer. Technol Cancer Res Treat 2005;4:645-650.
59. Takeda M, Tada H, Higuchi H, et al. In vivo single molecular imaging and sentinel node navigation by nanotechnology for molecular targeting drug-delivery systems and tailormade medicine. Breast Cancer 2008;15:145-152.
60. Sakamoto J, Annapragada A, Decuzzi P, Ferrari M. Antibiological barrier nanovector technology for cancer applications. Expert Opin Drug Deliv 2007;4:359-369.
61. Nie S, Xing Y, Kim GJ, Simons JW. Nanotechnology Applications in Cancer. Annu Rev Biomed Eng 2007;9:12.1-12.32.
62. Zhang H, Yee D, Wang C. Quantum dots for cancer diagnosis and therapy: Biological and clinical perspectives. Nanomedicine 2008;3:83-91.